CPH:NOVO-B

Novo Nordisk A/S Stock

DENMARK |CO |DKK

Price
kr645.70
Change
1.46%
Today's Range
kr634.10 - kr647.90
52-Week Range
kr401.31 - kr684.50
Market Cap
kr1.48T
Volume
2.12M

About Novo Nordisk A/S (CPH:NOVO-B)

(CPH:NOVO-B) Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Show more

NOVO-B Stock Price

Statistics Highlights (CPH:NOVO-B)

Shares Outstanding 1.75B Beta 0.27
Public Float 1.64B P/E Ratio 33.76
% Short of Float - Dividend (Yield) 9.35 (0.01%)
Held by Insiders 6.90% Ex-Dividend Date Aug 16, 2021
Held by Institutions 34.52% IPO Date -

NOVO-B Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue kr126.95B kr122.02B kr111.83B
EBITDA kr59.27B kr54.43B kr51.62B
Net Income kr42.14B kr38.95B kr38.63B
Total Assets kr144.92B kr125.61B kr110.77B
Total Cash kr12.76B kr15.47B kr15.64B
Total Debt kr kr kr
Jun 21 Mar 21 Dec 20
Revenue kr33.04B kr33.80B kr32.14B
EBITDA kr16.00B kr18.11B kr11.68B
Net Income kr12.12B kr12.62B kr9.32B
Total Assets kr158.09B kr141.39B kr144.92B
Total Cash kr24.23B kr5.68B kr12.76B
Total Debt kr kr kr

NOVO-B Stock Price History

Novo Nordisk A/S Annual Stock Price History

Year Open Close Change
2021 kr430.00 kr645.70 50.16%
2020 kr391.00 kr430.00 9.97%

Novo Nordisk A/S Daily Stock Price History

Date Open High Low Close Change Volume
Sep 16, 2021 kr636.20 kr647.90 kr634.10 kr645.70 1.46% 2.12M
Sep 15, 2021 kr634.00 kr640.00 kr629.50 kr636.40 0.79% 1.87M
Sep 14, 2021 kr629.70 kr636.00 kr624.20 kr631.40 0.27% 1.43M

(CPH:NOVO-B) Stock Price FAQs

What is today's stock price of Novo Nordisk A/S (CPH:NOVO-B)?

  • The current stock price of Novo Nordisk A/S (CPH:NOVO-B) is kr645.70.
  • Today NOVO-B stock price opened at kr636.20 after previous close of kr636.40.
  • During the day, Novo Nordisk A/S stock quote has varied from a low of kr634.10 to a high of kr647.90.

What is Novo Nordisk A/S's 52-week change?

  • NOVO-B 52-week high stock quote is kr684.50, which is 6.00% above the current share price.
  • The Novo Nordisk A/S (CPH:NOVO-B) 52-week low stock price is kr401.31, which is 37.80% below the current share price.
  • Novo Nordisk A/S share price volatility (52-week beta) is 0.27.

Novo Nordisk A/S (CPH:NOVO-B) FAQ

How Much is Novo nordisk a/s Worth?

Novo nordisk a/s's worth today based on market capitalisation is kr1.48T

How much money does Novo nordisk a/s make?

Last quarter (ended on June 30 ,2021) Novo nordisk a/s generated a net income of kr12.12B, representing a 12.36% decrease compared to the same quarter a year before (ended on June 30 ,2020).
Last fiscal year (ended on December 31 ,2020) Novo nordisk a/s generated a net income of kr42.14B, representing a 8.18% increase compare to the previous fiscal year (ended on December 31 ,2019).
View More Details on Novo nordisk a/s's “Financials” Section

How much dividend does Novo nordisk a/s Pay?

The current annualized dividend payout for NOVO-B stock is kr9.35, the dividend yield is 1.47% and the payout ratio is 30.59%.
View More Details on Novo nordisk a/s's "Dividend" Section

What were Novo nordisk a/s’s last Earnings results?

For the last quarterly earnings period (ended on June 30, 2021) NOVO-B reported kr5.26 EPS for the quarter.
View More Details on Novo nordisk a/s's 'Earnings' Section

What is Novo nordisk a/s’s Price to Earning (PE) ratio?

Novo nordisk a/s has a Price to Earning (P/E) ratio of 33.76. NOVO-B stock also has a Price to Sales (P/S) ratio of 11.36, a Price to Book of 22.23 and Price/Earnings to Growth (PEG) of 3.69.

What is the Novo nordisk a/s's ticker?

Novo nordisk a/s trades on the Copenhagen stock market in Denmark under the ticker symbol "NOVO-B". Novo nordisk a/s’s stock symbol can also be displayed as "CPH:NOVO-B".

Who are the owners of Novo nordisk a/s?

Novo nordisk a/s (CPH:NOVO-B) is owned by 34.52% institutional shareholders and by 6.90% insiders. The rest is owned by the public.
Explore More Details on Novo nordisk a/s's “Ownership” Section

Who are the key executives of Novo nordisk a/s (NOVO-B)?

Novo nordisk a/s's key executive team includes the following managers:

  • Mr. Lars Fruergaard Jorgensen, Pres, CEO & Member of Management Board (1966)
  • Mr. Karsten Munk Knudsen, Exec. VP, CFO & Member of the Management Board (1971)
  • Mr. Henrik Ehlers Wulff, Exec. VP, Head of Product Supply, Quality & IT and Member of the Management Board (1970)
  • Ms. Camilla Sylvest, Exec. VP, Head of Commercial Strategy & Corp. Affairs and Member of the Management Board (1972)
  • Ms. Monique Carter, Exec. VP, Head of People & Organisation and Member of Management Board (1973)
  • Mr. Maziar Mike Doustdar, Exec. VP, Head of International Operations & Member of the Management Board (1970)
  • Mr. Douglas J. Langa, Exec. VP, Head of North America Operations & Member of Management Board (1966)
  • Mr. Ludovic Helfgott, Exec. VP, Head of Biopharm & Member of Management Board (1974)
  • Mr. Martin Holst Lange, Exec. VP, Head of Devel. & Member of the Management Board (NA)
  • Mr. Marcus Schindler Ph.D., Exec. VP of Research & Early Devel., CSO and Member of the Management Board (1966)

What is Novo nordisk a/s’s Sector & Industry Classification?

Novo nordisk a/s (CPH:NOVO-B) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

What is the ESG rating for Novo nordisk a/s (CPH:NOVO-B) ?

ESG scores assess the degree to which a company’s enterprise business value is at risk driven by environmental, social, and governance issues. The scores are a measure of risk on an absolute scale of 0-100, with a lower score meaning less risk.

NOVO-B’s total ESG score is 25.83. The company’s environmental score is 3.16, social score is 14.95 and governance score is 13.21.
Novo nordisk a/s (CPH:NOVO-B) is involved in the following activities (which decreases its ESG score) : "animalTesting", "catholic".

How many employees work for Novo nordisk a/s?

Currently the number of employees working for Novo nordisk a/s is 45,971.

Where are Novo nordisk a/s's Headquarters?

Novo nordisk a/s (CPH:NOVO-B) is headquartered in Denmark.

What are Novo nordisk a/s's Address and Phone Number?

Novo nordisk a/s’s mailing address is Novo Allé 1, Bagsvaerd, Denmark, 2880.
The company’s phone number is 45 44 44 88 88.

What is the official website for Novo nordisk a/s?

Novo nordisk a/s’s official website is http://www.novonordisk.com